Latest articles from Cancer Therapy Advisor Hematologic Cancers
While BIA-ALCL had previously only been associated with breast implants, this case provides evidence for a possible case of gluteal implant-associated ALCL. from Latest articles from Cancer Therapy Advisor Hematologic Cancers h…
This fact sheet discusses the use of opioids to control cancer pain and the risks of substance use disorder. from Latest articles from Cancer Therapy Advisor Hematologic Cancers https://ift.tt/2Eq0YB6
Concerns about conflict of interest as it relates to prescribing may never go away, some say, as long as drug companies offer doctors money for consulting and personal services. from Latest articles from Cancer Therapy Advisor …
Clinical outcomes of patients with hypodiploid B-ALL are poor compared with those with B-ALL not characterized by hypodiploidy, according to researchers. from Latest articles from Cancer Therapy Advisor Hematologic Cancers http…
In a Canadian matched cohort study, intolerance drove patients with CP-CML to switch from generic imatinib at a higher frequency compared with those given brand-name products. from Latest articles from Cancer Therapy Advisor He…
In a statement announcing a newly created partnership, the Botanical Safety Consortium, FDA Commissioner Scott Gottlieb made no mention of cannabidiol. from Latest articles from Cancer Therapy Advisor Hematologic Cancers http:/…
Researchers examined low-level estimates of ambient benzene to investigate whether it was associated with increased cancer incidence across a nationwide cohort. from Latest articles from Cancer Therapy Advisor Hematologic Cance…
This fact sheet describes liquid biopsies and their uses in oncology. from Latest articles from Cancer Therapy Advisor Hematologic Cancers http://bit.ly/2GrEfqr
According to results of an exploratory study, patients with Richter transformation may benefit from treatment with ibrutinib plus nivolumab. from Latest articles from Cancer Therapy Advisor Hematologic Cancers http://bit.ly/2GJ…
Patients with newly-diagnosed DLBCL receiving R-CHOP at or near full-dose intensity have improved overall survival, according to study authors. from Latest articles from Cancer Therapy Advisor Hematologic Cancers http://bit.ly/…
"People have shown that the variant-identification quality of WGS is superior to WES," said Dr Gerstein. from Latest articles from Cancer Therapy Advisor Hematologic Cancers http://bit.ly/2Ib0XoE
A study of the use of precision-medicine based "radiomic" features to evaluate risk of refractory disease in early-stage Hodgkin lymphoma showed promising results. from Latest articles from Cancer Therapy Advisor Hema…
Given the high likelihood of comorbidities and poor performance status in older patients with PCNSL, alternative treatment approaches are needed for this population of patients. from Latest articles from Cancer Therapy Advisor …
Patient-reported outcomes, or PROs, are going to play a larger role in FDA cancer drug approvals, according to an expert in the field. from Latest articles from Cancer Therapy Advisor Hematologic Cancers http://bit.ly/2SITscq
The US FDA provided updated information to women with breast implants and their health care providers on the risk of developing a specific type of lymphoma. from Latest articles from Cancer Therapy Advisor Hematologic Cancers h…
Patients with B-ALL may benefit from sequential treatment with CD19 CAR-T therapy and anti-CD19 bispecific T-cell engager therapy regardless of sequence, according to a case study report. from Latest articles from Cancer Therap…
The rationale for how keto could influence cancer is based on the established differences in glucose metabolism between cancer cells and normal cells. from Latest articles from Cancer Therapy Advisor Hematologic Cancers http://…
Adults in the UK with R/R DLBCL and their health care providers now have the option of considering treatment with tisagenlecleucel, a CAR-T cell therapy. from Latest articles from Cancer Therapy Advisor Hematologic Cancers http…
Articles discussing the use of cannabis as a substitute for opioids highlight the limitations of the existing scientific evidence in the field. from Latest articles from Cancer Therapy Advisor Hematologic Cancers http://bit.ly/…
The continuous decline in cancer deaths over the past 25 years was attributed to improvements in screening, treatment. from Latest articles from Cancer Therapy Advisor Hematologic Cancers http://bit.ly/2HXijVI
